- Bayer AG press release (OTCPK:BAYZF): Q2 Non-GAAP EPS of €0.94.
- Revenue of €11.14B (+0.9% Y/Y).
- EBITDA before special items declines to €2.1 billion (– 16.5%), impacted by currency headwinds.
- Free cash flow at €1.3 billion.
- Net operating cash flow in the second quarter of 2024 amounted to €2,410 million (Q2 2023: €484 million).
- Group outlook confirmed: “We confirm our Group outlook for the year 2024 as published in the Annual Report 2023 and the Quarterly Statement for the first quarter of 2024. For the Crop Science Division, we expect currency- and portfolio-adjusted sales growth and the EBITDA margin before special items to come in at the lower end of the projected ranges. For the Pharmaceuticals Division, however, we now anticipate currency- and portfolio-adjusted sales growth of between 0% and 3% (previously: between minus 4% and 0%).”
Bayer AG Non-GAAP EPS of €0.94, income of €11.14B; reaffirms FY24 outlook | Invesloan.com
Updated:
